BIOPHARMA CONSULTANTS

LIVE

Serial Number

76348637

Owner

BIOPHARMA STRATEGIES GROUP, INC.

Attorney

Holly A. Coldiron

First Use Date

Nov 3, 2001

Filing Date

Dec 13, 2001

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

BIOPHARMA CONSULTANTS Trademark

Serial Number: 76348637 • Registration: 2720705

BIOPHARMA CONSULTANTS is a trademark filed by BIOPHARMA STRATEGIES GROUP, INC. on December 13, 2001. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Trademark Classes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

BIOPHARMA STRATEGIES GROUP, INC. (3 trademarks)

1439 PRESTON SPRING LANE
CHAPEL HILL, NC 27516

Entity Type: 03

BioPharma Consultants, Ltd. (2 trademarks)

1910 Sedwick Rd
Durham, NC 27713

Entity Type: 05

Legal Representation

Attorney of Record

Holly A. Coldiron

447 trademarks filed View all →

Trademark Details

Filing Date

December 13, 2001

Registration Date

June 3, 2003

First Use Anywhere

November 3, 2001

First Use in Commerce

November 3, 2001

Published for Opposition

March 11, 2003

Goods & Services

Consulting services relating to product development; preparation of governmental and regulatory agency filings in the fields of pharmaceuticals, biotechnology, and medical devices

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Nov 24, 2023 NA89

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

Nov 24, 2023 RNL2

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

Nov 24, 2023 89AG

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Nov 24, 2023 APRE

TEAS SECTION 8 & 9 RECEIVED

May 30, 2023 E89R

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Jun 3, 2022 REM2

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Sep 22, 2021 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Sep 22, 2021 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Sep 22, 2021 REAP

TEAS CHANGE OF CORRESPONDENCE RECEIVED

May 13, 2013 TCCA

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Feb 23, 2013 NA89

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

Feb 23, 2013 RNL1

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

Feb 23, 2013 89AG

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Feb 23, 2013 APRE

TEAS SECTION 8 & 9 RECEIVED

Feb 7, 2013 E89R

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Jun 5, 2009 C15A

ASSIGNED TO PARALEGAL

Jun 3, 2009 PLGL

TEAS SECTION 8 & 15 RECEIVED

Jun 1, 2009 E815

CASE FILE IN TICRS

Jun 24, 2008 CFIT

REGISTERED-PRINCIPAL REGISTER

Jun 3, 2003 R.PR

PUBLISHED FOR OPPOSITION

Mar 11, 2003 PUBO

NOTICE OF PUBLICATION

Feb 19, 2003 NPUB

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 27, 2002 CNSA

EXAMINERS AMENDMENT MAILED

Dec 13, 2002 CNEA

FINAL REFUSAL MAILED

Dec 10, 2002 CNFR

CORRESPONDENCE RECEIVED IN LAW OFFICE

Sep 11, 2002 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Sep 11, 2002 TROA

NON-FINAL ACTION MAILED

Mar 12, 2002 CNRT

ASSIGNED TO EXAMINER

Mar 6, 2002 DOCK

Related Trademarks

More from this Owner

BIOPHARMA STRATEGIES GROUP

BIOPHARMA CONSULTANTS

More in Same Class

TKE

CODA FINANCIAL INTELLIGENCE

ATTRA

SWANK CHICAGO

KYRIBA